KM Financial Solutions | UPDATE 1-Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst
27232
post-template-default,single,single-post,postid-27232,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst

UPDATE 1-Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst

U.S. drug prices fell again in
the second quarter, likely due to a new tactic insurers are
using to limit financial assistance drugmakers provide directly
to consumers, according to research firm Sector and Sovereign
Research (SSR).

No Comments

Sorry, the comment form is closed at this time.